Search Results for “EHR” – Page 13 – media

Janssen, Bayer Plans to Shut South Korean Plants Seeing a Plunging Demand

Janssen Korea becomes yet another drugmaker to shut its Hyangnam plant in Hwaseong, South Korea, by 2021, stranding an uncounted number of employees.
- Source: FiercePharma
- 684
- August 8, 2018
Company Insight pharmaceutical company South Korea
Merck Presents 96-Week Doravirine HIV Data Three Months before PDUFA Date

96-week data on doravirine, Merck’s HIV drug, was posted by the drugmaker recently. Merck expects it to outrun drugs like Bristol-Myers Squibb’s Sustiva in combination regimens and antiretroviral drugs from AbbVie and Johnson & Johnson in viral suppression.
- Source: FierceBiotech
- 897
- July 27, 2018
HIV Merck Researches
Biomedical Blockchain Research Center Opens at Mount Sinai

The opening of a new Biomedical Blockchain Research Center was announced by the Icahn School of Medicine at Mount Sinai and the Institute for Next Generation Healthcare which aims to solve healthcare and medical science issues with new technologies and data.
- Source: Healthcare IT News
- 801
- July 26, 2018
AI blockchain Company Insight EHR
AstraZeneca, Geisinger Come Together to Develop Asthma Care

Pharmaceutical giant AstraZeneca and integrated health services provider Geisinger are partnering to create an app suite, which by connecting to electronic health records (EHR) aims to upgrade asthma care.
- Source: The Verdict
- 917
- July 23, 2018
asthma Company Insight EHR mHealth
Investigational Therapy For ALS Extends Patient Survival

In the United States alone, there are an estimated 20,000 people living with amyotrophic lateral sclerosis (ALS), also called as Lou Gehrig's disease. The fatal disease destroys the nerve cells which control breathing, walking, and eating. Very few people survive more than three years after being diagnosed.
- Source: EurekAlert
- 534
- July 19, 2018
ALS Lou Gehrig's Disease Researches
Cerner & Lumeris Collaborate for Value-Based Care Solution

Cerner and Lumeris have brought together their technologies to result in EHR agnostic. The Kansas City, Missouri-based Cerner specializes in EHRs and other IT solutions whereas the St. Louis, Missouri-based Lumeris’ technique involves value-based care.
- Source: MedCityNews
- 820
- July 11, 2018
Company Insight EHR
Remote Patient Monitoring Startup could Spell Major Turning Point in Digital Health

Ambient Clinical Analytics, the remote patient monitoring firm which became independent from Mayo Clinic in 2013, has elevated $1.5 million in a round led by Noaber Ventures. Noaber Ventures is the extended investment arm of Noaber Foundation and the company’s first European investor. The already existing investors such as Mayo Clinic, Bluestem Capital and Social Capital have also contributed to the round.
- Source: MobiHealthNews
- 704
- June 22, 2018
Company Insight digital health EHR
IRANPHARMA EXPO 2018

The continuing increase in life expectancy, as one of the most important factors of development in societies, indicates the increasing focus on health and its ever booming market, with an estimated average return rate of 18 percent.
- Source: Ddu
- 16,481
- June 14, 2018
Exhibition & Activities IRANPHARMA EXPO
Parachute Health Received $9.5 Million Funding for ePrescribing Platform

The New York-based startup is aiming to digitize the equipment and to make the process easier through the ePrescribing platform. That way, the hospital doesn't spend time on faxing to communicate the order, and the patients and healthcare suppliers can get it quicker than they might have otherwise.
- Source: Business Insider
- 504
- June 5, 2018
Company Insight EHR
Amyotrophic Lateral Sclerosis Patients Found New Hope

Lou Gehrig disease which has no cure is finally seeing a ray of hope by Tel Aviv University researchers. The disease also called Amyotrophic lateral sclerosis (ALS) a neurodegenerative issue which causes muscles to atrophy and produces permanent disability in patients. The investigators say they may have found the basis of what could become a treatment for the devastating disease.
- Source: Ddu
- 474
- May 28, 2018
ALS Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.